National Health Investors Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 1 sell rating and 5 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors or view top-rated stocks.

Wall Street analysts have given National Health Investors a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but National Health Investors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

National Health Investors saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,330,000 shares, an increase of 26.7% from the August 15th total of 1,050,000 shares. Based on an average trading volume of 302,300 shares, the days-to-cover ratio is currently 4.4 days. Approximately 3.0% of the company's stock are short sold.
View National Health Investors' Short Interest.

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for National Health Investors.

National Health Investors, Inc. (NYSE:NHI) released its earnings results on Monday, August, 9th. The real estate investment trust reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.25 by $0.40. The real estate investment trust had revenue of $74.33 million for the quarter, compared to the consensus estimate of $77.22 million. National Health Investors had a trailing twelve-month return on equity of 10.04% and a net margin of 48.09%. The business's quarterly revenue was down 11.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.46 EPS.
View National Health Investors' earnings history.

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NHI shares have decreased by 19.8% and is now trading at $56.84.
View which stocks have been most impacted by COVID-19.

National Health Investors announced a quarterly dividend on Monday, August 9th. Shareholders of record on Thursday, September 30th will be paid a dividend of $0.90 per share on Friday, November 5th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 6.33%. The ex-dividend date is Wednesday, September 29th.
View National Health Investors' dividend history.

National Health Investors pays an annual dividend of $3.60 per share and currently has a dividend yield of 6.33%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of National Health Investors is 64.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, National Health Investors will have a dividend payout ratio of 67.92% next year. This indicates that National Health Investors will be able to sustain or increase its dividend.
View National Health Investors' dividend history.

6 Wall Street analysts have issued 12 month price targets for National Health Investors' stock. Their forecasts range from $55.00 to $77.00. On average, they expect National Health Investors' share price to reach $70.50 in the next twelve months. This suggests a possible upside of 24.0% from the stock's current price.
View analysts' price targets for National Health Investors or view top-rated stocks among Wall Street analysts.

Some companies that are related to National Health Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Extra Space Storage (EXR), Ventas (VTR), Medical Properties Trust (MPW), CubeSmart (CUBE), Life Storage (LSI), Omega Healthcare Investors (OHI), Rayonier (RYN), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR) and PotlatchDeltic (PCH).
View all of NHI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

National Health Investors' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (13.94%), BlackRock Inc. (9.86%), State Street Corp (3.81%), Goldman Sachs Group Inc. (2.31%), Geode Capital Management LLC (1.93%) and Bank of New York Mellon Corp (1.93%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors.

NHI stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Vanguard Group Inc., Principal Financial Group Inc., Kennedy Capital Management Inc., First Trust Advisors LP, BlackRock Inc., CapWealth Advisors LLC, and State Street Corp.
View insider buying and selling activity for National Health Investors or view top insider-selling stocks.

NHI stock was acquired by a variety of institutional investors in the last quarter, including Lasalle Investment Management Securities LLC, Sumitomo Mitsui Trust Holdings Inc., American Century Companies Inc., Invesco Ltd., Amundi, Millennium Management LLC, Liberty Wealth Management LLC, and Renaissance Technologies LLC. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors or or view top insider-buying stocks.

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NHI stock can currently be purchased for approximately $56.84.

National Health Investors has a market capitalization of $2.61 billion and generates $332.81 million in revenue each year. The real estate investment trust earns $185.13 million in net income (profit) each year or $5.60 on an earnings per share basis.

National Health Investors employs 20 workers across the globe.

National Health Investors was founded in 1991.

The official website for National Health Investors is www.nhireit.com.

National Health Investors is headquartered at 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129.

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at (615) 890-9100 or via email at [email protected].